Financhill
Sell
48

ALGN Quote, Financials, Valuation and Earnings

Last price:
$208.29
Seasonality move :
11.74%
Day range:
$206.00 - $212.49
52-week range:
$196.09 - $335.40
Dividend yield:
0%
P/E ratio:
35.54x
P/S ratio:
3.96x
P/B ratio:
3.94x
Volume:
507.7K
Avg. volume:
675.4K
1-year change:
-18.72%
Market cap:
$15.5B
Revenue:
$3.9B
EPS (TTM):
$5.86

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ALGN
Align Technology
$1B $2.44 4.86% 48.7% $264.08
BIOLQ
Biolase
$13.5M -$0.01 3.78% -99.71% $1.2000
BSX
Boston Scientific
$4.4B $0.66 18.45% 92.88% $99.42
MLSS
Milestone Scientific
$2.7M -$0.01 17.38% -66.67% --
NVST
Envista Holdings
$646.6M $0.23 0.24% -26.93% $21.42
XRAY
Dentsply Sirona
$921.1M $0.44 -8.99% 36.13% $23.11
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ALGN
Align Technology
$208.26 $264.08 $15.5B 35.54x $0.00 0% 3.96x
BIOLQ
Biolase
$0.0091 $1.2000 $331.2K -- $0.00 0% 0.00x
BSX
Boston Scientific
$90.69 $99.42 $133.7B 74.95x $0.00 0% 8.45x
MLSS
Milestone Scientific
$0.95 -- $74M -- $0.00 0% 8.39x
NVST
Envista Holdings
$19.03 $21.42 $3.3B -- $0.00 0% 1.31x
XRAY
Dentsply Sirona
$18.62 $23.11 $3.7B -- $0.16 3.44% 0.98x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ALGN
Align Technology
-- 2.501 -- 1.07x
BIOLQ
Biolase
142.17% -0.406 714.45% 0.23x
BSX
Boston Scientific
34.45% 0.507 8.79% 0.85x
MLSS
Milestone Scientific
-- 2.146 -- 1.42x
NVST
Envista Holdings
31.63% 0.497 41.83% 1.60x
XRAY
Dentsply Sirona
47.09% -0.130 41.22% 0.63x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ALGN
Align Technology
$681.8M $162.4M 11.69% 11.69% 16.6% $233.9M
BIOLQ
Biolase
$4.4M -$695K -129.74% -21668.17% -7.48% -$4.5M
BSX
Boston Scientific
$2.9B $718M 5.95% 8.91% 17.77% $698M
MLSS
Milestone Scientific
$1.8M -$1.5M -61.33% -61.33% -58.44% -$973.9K
NVST
Envista Holdings
$317.3M $20.9M -25.62% -35.84% 3.58% $63.3M
XRAY
Dentsply Sirona
$495M $64M -7.95% -13.34% -48.37% $98M

Align Technology vs. Competitors

  • Which has Higher Returns ALGN or BIOLQ?

    Biolase has a net margin of 11.86% compared to Align Technology's net margin of -13.16%. Align Technology's return on equity of 11.69% beat Biolase's return on equity of -21668.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.72% $1.55 $3.9B
    BIOLQ
    Biolase
    40.39% -$0.04 $12.4M
  • What do Analysts Say About ALGN or BIOLQ?

    Align Technology has a consensus price target of $264.08, signalling upside risk potential of 26.67%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 21999.45%. Given that Biolase has higher upside potential than Align Technology, analysts believe Biolase is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    7 6 0
    BIOLQ
    Biolase
    1 1 0
  • Is ALGN or BIOLQ More Risky?

    Align Technology has a beta of 1.671, which suggesting that the stock is 67.108% more volatile than S&P 500. In comparison Biolase has a beta of 0.690, suggesting its less volatile than the S&P 500 by 30.959%.

  • Which is a Better Dividend Stock ALGN or BIOLQ?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or BIOLQ?

    Align Technology quarterly revenues are $977.9M, which are larger than Biolase quarterly revenues of $10.9M. Align Technology's net income of $116M is higher than Biolase's net income of -$1.4M. Notably, Align Technology's price-to-earnings ratio is 35.54x while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.96x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.96x 35.54x $977.9M $116M
    BIOLQ
    Biolase
    0.00x -- $10.9M -$1.4M
  • Which has Higher Returns ALGN or BSX?

    Boston Scientific has a net margin of 11.86% compared to Align Technology's net margin of 11.12%. Align Technology's return on equity of 11.69% beat Boston Scientific's return on equity of 8.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.72% $1.55 $3.9B
    BSX
    Boston Scientific
    68.83% $0.32 $31.8B
  • What do Analysts Say About ALGN or BSX?

    Align Technology has a consensus price target of $264.08, signalling upside risk potential of 26.67%. On the other hand Boston Scientific has an analysts' consensus of $99.42 which suggests that it could grow by 9.62%. Given that Align Technology has higher upside potential than Boston Scientific, analysts believe Align Technology is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    7 6 0
    BSX
    Boston Scientific
    21 5 0
  • Is ALGN or BSX More Risky?

    Align Technology has a beta of 1.671, which suggesting that the stock is 67.108% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.800, suggesting its less volatile than the S&P 500 by 20.007%.

  • Which is a Better Dividend Stock ALGN or BSX?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Boston Scientific pays out 1.76% of its earnings as a dividend. Boston Scientific's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ALGN or BSX?

    Align Technology quarterly revenues are $977.9M, which are smaller than Boston Scientific quarterly revenues of $4.2B. Align Technology's net income of $116M is lower than Boston Scientific's net income of $468M. Notably, Align Technology's price-to-earnings ratio is 35.54x while Boston Scientific's PE ratio is 74.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.96x versus 8.45x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.96x 35.54x $977.9M $116M
    BSX
    Boston Scientific
    8.45x 74.95x $4.2B $468M
  • Which has Higher Returns ALGN or MLSS?

    Milestone Scientific has a net margin of 11.86% compared to Align Technology's net margin of -58.13%. Align Technology's return on equity of 11.69% beat Milestone Scientific's return on equity of -61.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.72% $1.55 $3.9B
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
  • What do Analysts Say About ALGN or MLSS?

    Align Technology has a consensus price target of $264.08, signalling upside risk potential of 26.67%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 123.68%. Given that Milestone Scientific has higher upside potential than Align Technology, analysts believe Milestone Scientific is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    7 6 0
    MLSS
    Milestone Scientific
    0 0 0
  • Is ALGN or MLSS More Risky?

    Align Technology has a beta of 1.671, which suggesting that the stock is 67.108% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.096, suggesting its more volatile than the S&P 500 by 9.625%.

  • Which is a Better Dividend Stock ALGN or MLSS?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or MLSS?

    Align Technology quarterly revenues are $977.9M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Align Technology's net income of $116M is higher than Milestone Scientific's net income of -$1.5M. Notably, Align Technology's price-to-earnings ratio is 35.54x while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.96x versus 8.39x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.96x 35.54x $977.9M $116M
    MLSS
    Milestone Scientific
    8.39x -- $2.5M -$1.5M
  • Which has Higher Returns ALGN or NVST?

    Envista Holdings has a net margin of 11.86% compared to Align Technology's net margin of 1.36%. Align Technology's return on equity of 11.69% beat Envista Holdings's return on equity of -35.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.72% $1.55 $3.9B
    NVST
    Envista Holdings
    52.8% $0.05 $4.5B
  • What do Analysts Say About ALGN or NVST?

    Align Technology has a consensus price target of $264.08, signalling upside risk potential of 26.67%. On the other hand Envista Holdings has an analysts' consensus of $21.42 which suggests that it could grow by 12.1%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    7 6 0
    NVST
    Envista Holdings
    3 10 1
  • Is ALGN or NVST More Risky?

    Align Technology has a beta of 1.671, which suggesting that the stock is 67.108% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.331, suggesting its more volatile than the S&P 500 by 33.125%.

  • Which is a Better Dividend Stock ALGN or NVST?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or NVST?

    Align Technology quarterly revenues are $977.9M, which are larger than Envista Holdings quarterly revenues of $601M. Align Technology's net income of $116M is higher than Envista Holdings's net income of $8.2M. Notably, Align Technology's price-to-earnings ratio is 35.54x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.96x versus 1.31x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.96x 35.54x $977.9M $116M
    NVST
    Envista Holdings
    1.31x -- $601M $8.2M
  • Which has Higher Returns ALGN or XRAY?

    Dentsply Sirona has a net margin of 11.86% compared to Align Technology's net margin of -51.95%. Align Technology's return on equity of 11.69% beat Dentsply Sirona's return on equity of -13.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.72% $1.55 $3.9B
    XRAY
    Dentsply Sirona
    52.05% -$2.46 $4.7B
  • What do Analysts Say About ALGN or XRAY?

    Align Technology has a consensus price target of $264.08, signalling upside risk potential of 26.67%. On the other hand Dentsply Sirona has an analysts' consensus of $23.11 which suggests that it could grow by 23.33%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    7 6 0
    XRAY
    Dentsply Sirona
    4 8 0
  • Is ALGN or XRAY More Risky?

    Align Technology has a beta of 1.671, which suggesting that the stock is 67.108% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.960, suggesting its less volatile than the S&P 500 by 4.04%.

  • Which is a Better Dividend Stock ALGN or XRAY?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 3.44% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -87.88% of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or XRAY?

    Align Technology quarterly revenues are $977.9M, which are larger than Dentsply Sirona quarterly revenues of $951M. Align Technology's net income of $116M is higher than Dentsply Sirona's net income of -$494M. Notably, Align Technology's price-to-earnings ratio is 35.54x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.96x versus 0.98x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.96x 35.54x $977.9M $116M
    XRAY
    Dentsply Sirona
    0.98x -- $951M -$494M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Companies Are In The VanEck Semiconductor ETF?
What Companies Are In The VanEck Semiconductor ETF?

There’s a lot to love about the VanEck Semiconductor ETF,…

How High Can Palantir Stock Go?
How High Can Palantir Stock Go?

Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…

Will This ETF Beat the Market Over the Next 12 Months?
Will This ETF Beat the Market Over the Next 12 Months?

2024 was another banner year for the US stock market,…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 121x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Sell
39
DOGZ alert for Jan 4

Dogness (International) [DOGZ] is down 20.52% over the past day.

Buy
66
DMRC alert for Jan 4

Digimarc [DMRC] is up 16.19% over the past day.

Sell
39
MSTR alert for Jan 4

MicroStrategy [MSTR] is up 13.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock